» Articles » PMID: 39740894

Transient Ischaemic Attack in a Patient With Conn Syndrome: A Case Report and Literature Review on the Importance of Identifying Secondary Hypertension

Overview
Journal In Vivo
Specialty Oncology
Date 2024 Dec 31
PMID 39740894
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aim: Transient ischaemic attack (TIA) is characterised by a temporary neurological dysfunction resulting from focal ischaemia in the brain, spinal cord or retina without acute infarction. These episodes typically last less than 24 hours and are significant predictors of subsequent ischaemic strokes. Hypertension is a major risk factor for cerebrovascular events, and primary aldosteronism (PA) is recognised as a common cause of secondary hypertension. This case report presents a male patient with secondary hypertension due to Conn Syndrome, a form of PA, who experienced a TIA manifesting as left leg weakness, underscoring the heightened stroke risk associated with secondary hypertension.

Case Report: A 78-year-old male with secondary hypertension caused by Conn Syndrome presented with an episode of left leg weakness that resolved within 24 hours. After ruling out other potential causes such as metabolic disturbances, infections, and structural brain lesions, he was diagnosed with TIA and treated with dual antiplatelet therapy. A carotid ultrasound revealed significant stenosis, leading to a referral for carotid endarterectomy. Long-term management included clopidogrel monotherapy and optimising hypertension control.

Conclusion: This case highlights the increased stroke risk in patients with Conn Syndrome-related hypertension, emphasising the importance of early recognition and optimising hypertension management in patients with secondary hypertension to prevent future cerebrovascular events.

References
1.
Shi J, Zhan Z, Zheng Z, Zhu X, Zhou X, Zhang S . Correlation of procalcitonin and c-reactive protein levels with pathogen distribution and infection localization in urinary tract infections. Sci Rep. 2023; 13(1):17164. PMC: 10567997. DOI: 10.1038/s41598-023-44451-6. View

2.
Kayser S, Dekkers T, Groenewoud H, van der Wilt G, Carel Bakx J, van der Wel M . Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis. J Clin Endocrinol Metab. 2016; 101(7):2826-35. DOI: 10.1210/jc.2016-1472. View

3.
Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A . Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013; 98(12):4826-33. DOI: 10.1210/jc.2013-2805. View

4.
Bibbins-Domingo K, C Grossman D, Curry S, Davidson K, Epling Jr J, Garcia F . Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016; 316(19):1997-2007. DOI: 10.1001/jama.2016.15450. View

5.
Freedman B, Potpara T, Lip G . Stroke prevention in atrial fibrillation. Lancet. 2016; 388(10046):806-17. DOI: 10.1016/S0140-6736(16)31257-0. View